Aldo-keto reductase inhibitors increase the anticancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Aldo-keto reductase inhibitors increase the anticancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia

Published:2021-09 Issue:1 Volume:147 Page:1-8
ISSN:1347-8613
Container-title:Journal of Pharmacological Sciences
language:en
Short-container-title:Journal of Pharmacological Sciences

Author:

Kikuya Megumi,Furuichi Kenta,Hirao Takuya,Endo Satoshi,Toyooka Naoki,Ito Kousei,Aoki Shigeki

Funder

Japan Society for the Promotion of Science

Yasuda Memorial Medical Foundation

Uehara Memorial Foundation

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine

Reference49 articles.

1. Cell signaling by receptor tyrosine kinases;Lemmon;Cell,2010

2. Activation of tyrosine kinases in cancer;Vlahovic;Oncol,2003

3. Molecular biology of bcr-abl1-positive chronic myeloid leukemia;Quintas-Cardama;Blood,2009

4. Expression of epidermal growth factor receptors in human lung tumors;Hwang;Cancer,1986

5. The HER2 signaling network in breast cancer--like a spider in its web;Dittrich;J Mammary Gland Biol Neoplasia,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-omics reveals AKR1B1-regulated galactose metabolic as a driver of gastrointestinal stromal tumor progression;2024-05-21

2. Aldo-keto reductase 1B: Much learned, much more to do;hLife;2023-12

3. Moving toward a new horizon for the aldose reductase inhibitor epalrestat to treat drug-resistant cancer;European Journal of Pharmacology;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP